Incyte (NASDAQ:INCY) today announced appointments among its executive leadership team to support the Company’s strategic focus and long-term growth plans. Pablo J. Cagnoni, M.D., has...
HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or the “Company”), a pharmaceutical manufacturer specializing in cannabis, is pleased to announce the...
Blue Matter today announced the launch of its People and Organization Practice, a dedicated capability designed to help life science companies build organizations that can...
Sotera Health Company (Nasdaq: SHC) (the “Company” or “Sotera Health”), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for...
Supporting 18 of the top 50 pharmaceutical companies in the world with its industry-leading clinical data intelligence platform, the company eyes its next phase of...
Veteran marketing and communications leader to drive organizational strategy and advance Guardian Recovery’s mission as a national behavioral health leader Guardian Recovery, one of the...
Former Rune Labs and Glooko executive to lead MindMaze’s next phase of growth, focusing on U.S. market expansion and the delivery of scalable, AI-driven neurorestorative...
Prominently featured in The Inner Circle, Courtney M. Preston is acknowledged as a Top Pinnacle Professional for her contributions to the field of neurology. Dr....
Georgia healthcare leader brings deep market expertise, operational excellence, and strong community relationships Anthem Blue Cross and Blue Shield of Georgia today announced that Amanda...
As Interim President, Cherie Myatt will provide executive leadership across the organization, reinforcing Vaniam Group’s long-term commitment to value creation. Vaniam Group announced today that...
Lario Therapeutics (“Lario” or the “Company”), a biopharmaceutical company developing first-in-class precision medicines for epileptic and neurological disorders, today announced it has received a total...
GenSight Biologics (“GenSight Biologics” or the “Company“) (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for...
Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company specializing in the development of novel therapies to restore, treat and prevent hearing loss disorders, today announced...
Brings deep expertise in immunology, oncology and pharmacology with a strong track record of advancing innovative pipelines through discovery and translation into the clinic Reflects...
The new Public Television segment examines patient-centered care, surgical discipline, and ethical considerations within the modern field of aesthetic medicine. Public Television audiences will soon...